It’s now official: as of October 17, 2018, Canada will become the first G7 nation to legalize both medical and adult-use recreational cannabis. It’s a historic, disruptive and uncertain moment.
The Guardian newspaper recently pointed out that “all eyes” are now on Canada. Those eyes are watching to see how this public policy will be deployed and what the ripple effects will be on crime, health, consumer spending, public safety, job creation and more.
How legalization will roll out in Canada in the next 18 months will also have a significant impact on the rate and number of other countries following suit. The shift will have a series of implications, including decreasing prescription opioid use and helping end the disproportionate impact that criminalizing cannabis has on low-income communities and communities of colour. Furthermore, Canada’s bold cannabis policy has become linked to our global credibility, particularly as it relates to successfully undertaking significant policy shifts.
Read on, from Policy Options, here.
Four Issues to be resolved in cannabis legalization, by Reva Seth
It’s now official: as of October 17, 2018, Canada will become the first G7 nation to legalize both medical and adult-use recreational cannabis. It’s a historic, disruptive and uncertain moment.
The Guardian newspaper recently pointed out that “all eyes” are now on Canada. Those eyes are watching to see how this public policy will be deployed and what the ripple effects will be on crime, health, consumer spending, public safety, job creation and more.
How legalization will roll out in Canada in the next 18 months will also have a significant impact on the rate and number of other countries following suit. The shift will have a series of implications, including decreasing prescription opioid use and helping end the disproportionate impact that criminalizing cannabis has on low-income communities and communities of colour. Furthermore, Canada’s bold cannabis policy has become linked to our global credibility, particularly as it relates to successfully undertaking significant policy shifts.
Read on, from Policy Options, here.
Relm Risk Briefing: Cannabis 2026
The global cannabis sector has moved from experiment to enterprise. This comprehensive risk briefing examines how regulation, insurance, and operational practices intersect across the international supply chain, drawing on insights from RELM—the only insurer entirely dedicated to the cannabis industry.
What's covered
Key insights
Download Relm Risk Briefing: Cannabis 2026
Get your free copy of the comprehensive risk analysis report.
Mayor Don Darling, Mayor, Saint John, New Brunswick
Next PostQuick Hits with Keith Merker, CEO, WeedMD
BofC
Related Posts
Related Posts
Seven Years for Progress, Four Days to Undermine It: The UK’s Cannabis Media Storm
On 6 January 2026, the National Police Chiefs' Council (NPCC) approved the first official guidance on medical cannabis for officers...
France’s First Prescriptions ‘Unlikely This Year’ Despite ‘Complete’ Framework
Last week, France’s now five-year old medical cannabis pilot programme was extended once again, providing a bridge beyond March 2026...
UK CBD Approvals Face Autumn 2026 Crunch as Industry Proposes Framework Overhaul
France Extends Medical Cannabis Access Again as Full Access Bill Remains Stuck in Limbo
Relm and Prohibition Partners Launch Cannabis Risk Briefing for Emerging and High-Growth Industries
The Battle for Germany’s Medical Cannabis Market: Who’s Fighting for What
Cannabis Europa Paris
Europe’s leading cannabis policy, business and investment conference — bringing senior decision-makers together in Paris.
CONNECT
Related Posts
Related Posts
Seven Years for Progress, Four Days to Undermine It: The UK’s Cannabis Media Storm
On 6 January 2026, the National Police Chiefs' Council (NPCC) approved the first official guidance on medical cannabis for officers...
France’s First Prescriptions ‘Unlikely This Year’ Despite ‘Complete’ Framework
Last week, France’s now five-year old medical cannabis pilot programme was extended once again, providing a bridge beyond March 2026...
UK CBD Approvals Face Autumn 2026 Crunch as Industry Proposes Framework Overhaul
The UK's first-ever CBD product authorisations, originally expected to be completed by Autumn 2026, could now face another setback as...
France Extends Medical Cannabis Access Again as Full Access Bill Remains Stuck in Limbo
Thousands of French medical cannabis patients will continue to receive their treatment for the foreseeable future, as the highly anticipated...
Relm and Prohibition Partners Launch Cannabis Risk Briefing for Emerging and High-Growth Industries
Relm Insurance (Relm), the leading insurer focused on emerging industries, today released its Risk Briefing: Cannabis 2026, an inaugural global...
Recent Posts
Related Posts
Relm and Prohibition Partners Launch Cannabis Risk Briefing for Emerging and High-Growth Industries
Relm Insurance (Relm), the leading insurer focused on emerging industries, today released its Risk Briefing: Cannabis 2026, an inaugural global...
UK Police Finally Get Official Medical Cannabis Guidance More Than 7 Years After Legalisation
Over seven years after medical cannabis was legalised in the UK, the National Police Chiefs' Council has approved the first...
Countdown to Business of Cannabis: New York 2025, Celebrating Our Pioneering Sponsors
Next Thursday, 6 November 2025, Business of Cannabis: New York returns to The Wythe Hotel, Williamsburg, uniting more than 300...
Business of Cannabis Awards 2025: We Have Our Winners
The shortlist for the second annual Business of Cannabis Awards, Europe’s leading celebration of excellence across the cannabis sector, have...
Business of Cannabis Awards 2025: Full List of Nominees Revealed
The shortlist for the second annual Business of Cannabis Awards, Europe’s leading celebration of excellence across the cannabis sector, have...
Subscribe to our mailing list to receives daily updates!
We won’t spam you
Categories
Browse by Tags